Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs.
Lockdown Tied to Worsening of Musculoskeletal Conditions
TUESDAY, Sept. 29, 2020 (HealthDay News) — Early stages of the U.K. COVID-19 lockdown had negative consequences for people with musculoskeletal conditions, according to a letter to the editor published online Sept. 22 in Rheumatology: Advances in Practice.
Private Health Plans Pay Hospitals 247 Percent of Medicare
MONDAY, Sept. 28, 2020 (HealthDay News) — During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.
Hip Implant Survival Tied to Implant Choice
MONDAY, Sept. 21, 2020 (HealthDay News) — Between-hospital variation in survival rates of total hip replacement (THR) may be due to implant choice, according to a U.K. study published online Aug. 31 in PLOS Medicine.
Botox for TMJ Disorder Does Not Affect Jaw Bone Density
FRIDAY, Sept. 18, 2020 (HealthDay News) — Jaw bone density and volume are similar between women who had botulinum toxin (BTX) injections to treat temporomandibular muscle and joint disorders (TMJDs) and those who did not, according to a small study published online Sept. 3 in the Journal of Oral Rehabilitation.
Obstructive Sleep Apnea Tied to Worse Bone Health
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — History of obstructive sleep apnea (OSA) is independently associated with a higher risk for confirmed vertebral fracture, according to a study published online Sept. 9 in the Journal of Bone and Mineral Research.
Curcuma longa Extract Improves Knee Pain in Osteoarthritis
TUESDAY, Sept. 15, 2020 (HealthDay News) — For patients with knee osteoarthritis, Curcuma longa extract (CL) is more effective than placebo for knee pain but does not improve knee effusion-synovitis, according to a study published online Sept. 15 in the Annals of Internal Medicine.
Clinical Score Predicts Poor Pain Control After Spine Surgery